BioLASCO Taiwan Co., Ltd. (TPEX:6662)
Taiwan
· Delayed Price · Currency is TWD 33.00
-0.35 (-1.05%)
May 2, 2025, 1:02 PM CST
BioLASCO Taiwan Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 292.5 | 264.72 | 235.91 | 227.58 | 298.88 | Upgrade
|
| Revenue Growth (YoY) | 10.49% | 12.21% | 3.66% | -23.86% | -13.79% | Upgrade
|
| Cost of Revenue | 177.74 | 160.37 | 131.43 | 122.47 | 168.58 | Upgrade
|
| Gross Profit | 114.76 | 104.35 | 104.49 | 105.11 | 130.3 | Upgrade
|
| Selling, General & Admin | 59.06 | 53.54 | 55.22 | 51.18 | 52.74 | Upgrade
|
| Operating Expenses | 59.02 | 53.59 | 55.22 | 51.21 | 52.74 | Upgrade
|
| Operating Income | 55.74 | 50.76 | 49.27 | 53.89 | 77.56 | Upgrade
|
| Interest Expense | -1.76 | -1.3 | -1.09 | -0.88 | -0.77 | Upgrade
|
| Interest & Investment Income | 2.41 | 1.83 | 0.73 | 0.47 | 0.56 | Upgrade
|
| Earnings From Equity Investments | 1.72 | 8.72 | 4.68 | 2.72 | 0.64 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.18 | 0.31 | -0.52 | 0.2 | 0.44 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.28 | 1.66 | 0.05 | 0.04 | 0.07 | Upgrade
|
| EBT Excluding Unusual Items | 58.56 | 61.99 | 53.14 | 56.44 | 78.49 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | -0.01 | Upgrade
|
| Asset Writedown | - | - | - | - | 0.01 | Upgrade
|
| Other Unusual Items | -3.64 | - | - | - | 0.01 | Upgrade
|
| Pretax Income | 54.92 | 61.99 | 53.14 | 56.44 | 78.5 | Upgrade
|
| Income Tax Expense | 10.89 | 12.25 | 10.83 | 11.29 | 15.7 | Upgrade
|
| Earnings From Continuing Operations | 44.03 | 49.74 | 42.31 | 45.15 | 62.8 | Upgrade
|
| Net Income | 44.03 | 49.74 | 42.31 | 45.15 | 62.8 | Upgrade
|
| Net Income to Common | 44.03 | 49.74 | 42.31 | 45.15 | 62.8 | Upgrade
|
| Net Income Growth | -11.49% | 17.57% | -6.29% | -28.10% | 14.24% | Upgrade
|
| Shares Outstanding (Basic) | 26 | 26 | 26 | 26 | 26 | Upgrade
|
| Shares Outstanding (Diluted) | 26 | 26 | 26 | 26 | 26 | Upgrade
|
| Shares Change (YoY) | -0.02% | -0.00% | -0.02% | -0.03% | 2.08% | Upgrade
|
| EPS (Basic) | 1.72 | 1.94 | 1.65 | 1.76 | 2.45 | Upgrade
|
| EPS (Diluted) | 1.72 | 1.94 | 1.65 | 1.76 | 2.45 | Upgrade
|
| EPS Growth | -11.39% | 17.58% | -6.25% | -28.16% | 11.88% | Upgrade
|
| Free Cash Flow | 1.04 | 27.83 | 40.88 | 66.62 | -40.89 | Upgrade
|
| Free Cash Flow Per Share | 0.04 | 1.08 | 1.59 | 2.60 | -1.59 | Upgrade
|
| Dividend Per Share | - | 1.650 | 1.500 | 1.600 | 2.000 | Upgrade
|
| Dividend Growth | - | 10.00% | -6.25% | -20.00% | 5.26% | Upgrade
|
| Gross Margin | 39.23% | 39.42% | 44.29% | 46.18% | 43.59% | Upgrade
|
| Operating Margin | 19.06% | 19.18% | 20.88% | 23.68% | 25.95% | Upgrade
|
| Profit Margin | 15.05% | 18.79% | 17.94% | 19.84% | 21.01% | Upgrade
|
| Free Cash Flow Margin | 0.35% | 10.51% | 17.33% | 29.27% | -13.68% | Upgrade
|
| EBITDA | 64.45 | 58.96 | 56.91 | 62.07 | 85.24 | Upgrade
|
| EBITDA Margin | 22.04% | 22.27% | 24.12% | 27.27% | 28.52% | Upgrade
|
| D&A For EBITDA | 8.71 | 8.2 | 7.64 | 8.18 | 7.68 | Upgrade
|
| EBIT | 55.74 | 50.76 | 49.27 | 53.89 | 77.56 | Upgrade
|
| EBIT Margin | 19.06% | 19.18% | 20.88% | 23.68% | 25.95% | Upgrade
|
| Effective Tax Rate | 19.83% | 19.76% | 20.38% | 20.00% | 20.00% | Upgrade
|
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.